Osteoporotic Cytokines and Bone Metabolism on Rats with Induced Hyperthyroidism; Changes as a Result of Reversal to Euthyroidism

Gönül Simsek；Yesari Karter；Seval Aydın；Hafize Uzun

Hyperthyroidism ； interleukin-1β ； interleukin 6, tumor necrosis factor-α, bone metabolism, bone turnover

The Chinese Journal of Physiology

46卷4期（2003 / 12 / 01）

181 - 186

英文

Hyperthyroidism is characterized by increased bone turnover and resorptive activity. Raised levels of serum osteoporotic cytokines, such as interleukin (IL) -1, IL-6 and tumor necrosis factor (TNF)-have been demonstrated previously in hyperthyroidism. These elevations are controversial and it is difficult to differentiate the contribution of thyroid hormones to the elevation of cytokines from that of the autoimmune inflammation in Graves’ disease (GD) and follicular cell damage in thyroiditis. Therefore, we investigated the effect of thyroid hormones on serum IL-1, IL-6, TNF-levels and bone metabolism on L-thyroxine induced hyperthyroid rats and changes in cytokine levels and bone metabolism on the same rats after reversal to euthyroidism. Rats were treated with L-thyroxine for 5 weeks (0.4 mg/ 100 g food). Plasma T3, T4, TSH and serum IL-1, IL-6, TNF, Calcium (Ca), phosphorous (P), parathyroid hormone (PTH), alkaline phosphatase (ALP), bone alkaline phosphatase (B-ALP) levels were measured and differential leucocyte counts were made initially, at the 5th week of the experiment (hyperthyroid state) and 5 weeks after quitting the administration of L-thyroxine (euthyroid state). Significant rises in serum IL-1, IL-6 and TNFwere noted in hyperthyroidism (P＜0.001). In euthyroid state, IL-1, IL-6 and TNFdecreased significantly, but IL-and TNFwere significantly higher than the baseline values (P＜0.05) while IL-6 levels turned back to the baseline values. Plasma T3 and T4 levels were significantly correlated with serum cytokines in hyperthyroid state while there was no correlation in euthyroid states. Ca and P levels did not differ significantly while PTH levels declined significantly in the hyperthyroid state (P＜0.05). After the reversal to the euthyroidism, there was no significant change in Ca, P and PTH levels. ALP and B-ALP increased significantly in hyperthyroidism (P＜ 0.001, P＜0.01) and they did not decrease in euthyroid state. The lymphocyte number and ratio in differentials increased significantly in the hyperthyroid state (P＜0.001). In euthyroidism they decreased significantly (P＜0.001) but it was significantly higher than the baseline value (P＜0.05). Our findings showed that the deleterious effect on bone metabolism in hyperthyroidism might be mediated by cytokines and the increased bone turnover in hyperthyroidism failed to decrease despite euthyroidism.

1. Ahmad, L.,Parkes, A.,Lazarus, J.,Bartalena, L.,Martino, E.,Diamond, E.,Stagnaro-Green, A.(1998).Interleukin-6 levels are not increased in women with postpartum thyroid dysfunction.Thyroid,8,371-375.
2. Barnefalk, E.,Ljunghall, S.,Lindh, E.,Bengston, O.,Johansson, A. G.,Ljunggren, O.(1997).Regulation of interleukin-6 secretion from mononuclear blood cells by extracellular calcium.J. Bone. Miner,12,228-233.
3. Bartalena, L.,Brogioni, S.,Grasso, L.,Martino, E.(1993).Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4- binding globulin concentration.J. Endocrinol. Invest,16,213-218.
4. Barun, D.T.(1994).Detrimental skeletal effectts of thyrotropin suppressive doses of thyroxine: fact or fantasy?.J. Clin. Endocrinol. Metabolism,78,816-817.
5. Bisbocci, D.,Gallo, V.,Damiano, P.,Sidoli, L.,Cantoni, R.,Aimo, G.,Priolo, G.,Pagni, R.,Chiandussi, L.(1996).Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy.J. Endocrinol. Invest,19,511-515.
6. Buergi, U.,Larsen, P.R.(1982).Nuclear triiodothyronine binding in mononuclear leukocytes in normal subjects and obese patients before and after fasting.J. Clin. Endocrinol. Metab,54,1199-1205.
7. Celik, I.,Akalin, S.,Erbas, T.(1995).Serum levels of interleukin-6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.Eur. J. Endocrinol,132,668-672.
8. Eriksen, E.F.,Kessem, M.(1992).The cellular basis of bone remodelling.J. Med. Sci,31,45-57.
9. Ganong, W.F.(1999).Circulating Body Fluids Stamford.Appleton & Lange.
10. Garnero, P.,Vassy, V.,Bertholin, A.,Riou, J.P.,Delman, P.D.(1994).Markers of bone turnover in hyperthyroidism and the effect of treatment.J. Clin. Endocrinol. Metab,78,955-959.
11. Gauldie, J.,Richards, C.,Horbish, D.,Lansdorp, P.,Baumann, H.(1987).Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proc. Natl. Acad Sci USA,84,7251-7255.
12. Girasole, G.,Jilka, R.L.,Passeri, G.,Boswell, S.,Boder, G.,Williams, D.C.,Manolagas, S.C.(1992).17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.J Clin Invest,89,883-891.
13. Heuer, M.,Aust, G.,Ode-Hakim, S.,Scherbaum, W.A.(1996).Different cytokine mRNA profiles in Graves` disease, Hashimoto`s thyroiditis, and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RTPCR).Thyroid,6,97-106.
14. Horowitz, M.C.(1993).Cytokines and estrogen in bone: anti-osteoporotic effects.Science,260,626-627.
15. Karaturan, N.,SimSek, G.,Güner, I.,Sahin, G.,Oruç, T.,Hatemi, H.(2001).Hipertrioidi oluSturulmus anestezi altindaki tavSanlarda apneik düzeyde solunum faaliyeti, hipoksi ve hiperkapniye karSı duyarlılıgın incelenmesi.J. Turkish. Anaest. Rean,29,4-9.
16. Kurihara, N.,Bertolini, D.,Sida, T.,Akiyama, Y.,Roodman, G. D.(1990).IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release.J. Immunol,144,4226-4230.
17. Lakatos, P.,Foldes, J.,Horvath, C.,Kiss, L.,Tatrai, A.,Takacs, I.,Tarjan, G.,Stern, P.H.(1997).Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.J. Clin. Endocrinol. Metab,82,78-81.
18. Langdahl, B.L.,Loft, A.G.R.,Eriksen, E.F.,Mosekilde, L.,Charles, P.(1996).Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy.Thyroid,6,161-168.
19. Mc Lead, K.J.,Rubin, C.T.,Otter, M.W.,Qin, Y.X.(1998).Skeletal cell. Stresses and bone adaptation.Am. J. Med. Sci,316,176-183.
20. Minelli, R.,Girasole, G.,Pedrazzoni, M.,Giuliani, N.,Schianchi, C.,Giuberti, T.,Braverman, L.E.,Salvi, M.,Roti, E.(1996).Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy.J. Investig. Med,44,370-374.
21. Molnar, I.,Balazs, C.(1997).High circulating IL-6 level in Graves` ophthalmopathy.Autoimmunity,25,91-96.
22. Monolagas, S.C.,Jilka, R.L.,Girasole, G.,Passeri, G.,Bellido, T.,Kohler PO(edited)(1994).Current opinion in endocrinology and diabetes.Philadelphia, Current Science.
23. Mudde, A.H.,Houben, A.J.,Nieuwenhuijzen Kruseman, A.C.(1994).Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism.Clin.. Endocrinol (Oxf),41,421-424.
24. Mundy, G.R.,Shapiro, J.L.,Bandelin, J.G.,Canalis, E.M.,Raisz, L.G.(1976).Direct stimulation of bone resorption by thyroid hormones.J. Clin. Invest,58,529-534.
25. Pumarino, H.,Pumarino, M.G.(1996).Cytokines, growth factors, and metabolic bone disease.Rev. Med. Chil,124,248-257.
26. Rizzoli, R.,Poser, J.,Burgi, U.(1986).Nuclear thyroid hormone receptors in cultured bone cells.Metabolism,35,71-74.
27. Schaffer, R.B.,Gregory, D.H.(1972).Calcium malabsorption in hyperthyroidism.Gastroenterology,63,235.
28. Siddiqi, A.,Burrin, J.M.,Wood, D.F.,Monson, J.P.(1998).Triiodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells.J. Endocrinol,157,453-461.
29. Siddiqi, A.,Monson, J.P.,Wood, D.F.,Besser, G.M.,Burrin, J. M.(1999).Serum cytokines in thyrotoxicosis.J. Clin. Endocrinol. Metab,84,435-439.
30. Simsek, G.,Andican, G.,Karakoç, Y.,Yigit, G.,Hatemi, H.,Candan, G.(1997).Calcium, magnesium and zinc status in experimental hypothyroidism. Biol.Trace. Element. Res,60,205-213.
31. Simsek, G.,Andican, G.,Unal, E.,Hatemi, H.,Yigit, G.,Candan, G.(1997).Calcium, magnesium, and zinc status in experimental hyperthyroidism.Biol. Trace. Elem. Res,57,131-137.
32. Simsek, G.,Aydın, S.,Uzun, H.,Karter, Y.,Yigit, G.,Dondurmacı, S.,Hatemi, H.(1997).The role of cytokines in bone metabolism of rats with induced hyperthyroidism.Med. Sci. Res,25,421-423.
33. Tarjan, G.,Stern, P.H.(1995).Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures.J. Bone Miner. Res,10,1321-1326.
34. Toh, SH.,Claunch, B.C.,Brown, P.H.(1985).Effect of hyperthyroidism and its treatment on bone mineral content.Arch. Intern. Med,145,883-886.
35. Toktamıs, N.,Seven, A.,Hacıbekiroglu, M.,Yigit, G.,Candan, G.,Hatemi, S.,Hatemi H.(1993).Fe parameters and euthrocytic parameters in experimental hyperthyroidism.Biochem. Soc. Trans,21,223.
36. Watson, P.F.,Pickerill, A.P.,Davies, R.,Weetman, A.P.(1994).Analysis of cytokine gene expression in Graves` disease and multinodular goiter.J. Clin. Endocrinol. Metab,79,355-360.

1. Wang, Ming-Fu,Liu, Mei-Hui,Chen, Chun-Chi,Chen, Cheng-Chin(2007).Effects of Aging and Dietary Antler Supplementation on the Calcium-Regulating Hormones and Bone Status in Ovariectomized SAMP8 Mice.Chinese Journal of Physiology,50(6),308-314.
2. Yesari Karter,Volkan Sozer,Seval Aydin,Safiye Kaya,Rifat Yucel,Ibrahim Guner,Hafize Uzun,Gunnur Yigit,Gonul Simsek,Cahit Simsek(2006).Bone Metabolism in Ovariectomized Rats with Induced Hyperthyroidism: The Effect of Estrogen Replacement.Chinese Journal of Physiology,49(6),335-341.